Xconomy Boston

$10M for Akorri, $52M for Dyax, A New Partner for Dicerna, & More Boston-Area Deals News

Rebecca Zacks3/31/10Leave a Comment

The precipitation in New England may have reached near-biblical proportions this past week, but tech and life sciences deal making was more modest.

Investors poured $10.1 million into Littleton, MA-based software maker Akorri Networks, according to an SEC filing. The filing did not reveal the identity of the 13 backers involved in the equity-based round, but Akorri’s website lists Matrix Partners, North Bridge Venture Partners, Globespan Capital Partners, BlueStream Ventures, and Montagu Newhall Associates as existing investors.

—Erin took a look at the “under-the-radar” deals that New England tech and life sciences companies cut last month. These 26 sub-$1 million deals—rounded up for us by our partner, CB Insights, a New York-based private company intelligence platform—included companies focused on software, medical devices, health IT, used clothing, and more.

—Cambridge, MA-based drug maker Dyax (NASDAQ: DYAX) raised $51.8 million in an offering of 17 million shares of stock at $3.25 apiece.

—Software maker Azigo of Wellesley, MA, raised $1.8 million in an equity offering, according to an SEC filing. Ten investors participated in the round.

—Enterprise software maker Rocket Software of Newton, MA, announced it will acquire Waltham, MA-based data management company Computer Corporation of America for an undisclosed sum.

—Dicerna Pharmaceuticals, the Watertown, MA-based developer of RNA interference drugs, cut a deal with Paris-based Ipsen to develop drugs for oncology and endocrinology. No financial terms were disclosed, but Dicerna chief business officer Martin Williams described the deal as being “net-neutral” to Dicerna.

—CardStar, a Canton, CT-based maker of software for storing consumer reward and loyalty card numbers on mobile phones, raised $1 million in Series A venture funding. The deal was led by Amplifier Ventures and joined by Acta Wireless and LaunchCapital.

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.